|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.9 TWD | -0.52% |
|
+2.30% | -26.37% |
Golden Biotechnology Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 217.83 million compared to TWD 81.77 million a year ago. Net loss was TWD 271.88 million compared to TWD 443.84 million a year ago.
Basic loss per share from continuing operations was TWD 1.91 compared to TWD 3.35 a year ago. Diluted loss per share from continuing operations was TWD 1.91 compared to TWD 3.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.37% | 126M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
GOLDEN BIOTECHNOLOGY CORPORATION 
